Xpress Biologics


Xpress Biologics is a Contract Development and Manufacturing Organization (CDMO) specialized in the development of manufacturing processes for the production of Biologics (recombinant proteins, antibody fragments and DNA) for therapeutic, vaccine and diagnostic applications.

The services proposed by Xpress Biologics include the manufacturing of plasmid DNA for the development of DNA vaccines and the production of viral vectors and mRNA.

The production scale goes from 100 mg to 20 g of purified DNA.

The production of R&D, HQ (High-Quality) and, starting in Q1 2023, GMP grade material is proposed.